Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial : <u>V</u>enous thromboembolism prophyl<u>A</u>xis after gyneco<u>L</u>ogical p<u>E</u>lvic cancer surgery with <u>RI</u>varoxaban versus enox<u>A</u>parin (VALERIA trial).
第一单位:
São Paulo State Public Women's Health Reference Center, São Paulo, Brazil.
作者:
医学主题词
人类(Humans);依诺肝素(Enoxaparin);静脉血栓栓塞(Venous Thromboembolism);抗凝药(Anticoagulants);盆腔肿瘤(Pelvic Neoplasms);肝素, 低分子量(Heparin, Low-Molecular-Weight)
DOI
10.1177/10760296221132556
PMID
36474344
发布时间
2022-12-15
- 浏览0
Clinical and applied thrombosis/hemostasis
10760296221132556页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



